#1 Clinical Trials Search in Europe

Modafinil

Modafinil, also known by its brand name Provigil, is a wakefulness-promoting drug that has been the subject of numerous clinical trials exploring its potential benefits for various medical conditions. This article summarizes key findings from recent studies investigating modafinil’s effects on cognitive function, fatigue, sleepiness, and other symptoms across different patient populations.

Table of Contents

What is Modafinil?

Modafinil is a medication that promotes wakefulness and alertness. It is known by several brand names, including Provigil, Alertec, and 2-benzhydrylsulfinylacetamide[1]. Modafinil is classified as a psychostimulant, which means it stimulates certain areas of the brain to increase alertness and cognitive function[2].

Medical Uses of Modafinil

Modafinil is approved by the FDA for treating several conditions related to excessive sleepiness and fatigue:

  • Narcolepsy: A sleep disorder that causes excessive daytime sleepiness[3].
  • Shift Work Sleep Disorder: A condition affecting people who work non-traditional hours[3].
  • Obstructive Sleep Apnea: A disorder where breathing is repeatedly interrupted during sleep[3].

Additionally, researchers are exploring the use of modafinil for other conditions:

  • Depression: To help with fatigue and cognitive symptoms that persist even after mood improves[3][1].
  • Cancer-related fatigue: To help cancer patients manage extreme tiredness[4][5].
  • Multiple Sclerosis (MS): To address fatigue in MS patients[6].
  • Cognitive enhancement: To potentially improve memory, attention, and other cognitive functions in healthy individuals[7].
  • Substance abuse disorders: As a potential treatment for cocaine and methamphetamine addiction[8][9].
  • Post-Traumatic Stress Disorder (PTSD): To help with attention and concentration issues in PTSD patients[10].

How Modafinil Works

The exact mechanism of how modafinil works is not fully understood. However, researchers believe it affects certain chemicals in the brain, particularly dopamine. Modafinil is thought to:

  • Increase dopamine levels in the brain, which helps with alertness and focus[5].
  • Enhance cognitive functions such as attention, memory, and executive function (the ability to plan and execute tasks)[1].
  • Promote wakefulness without causing the “high” or addictive potential associated with other stimulants[9].

Dosage Information

The typical dosage of modafinil varies depending on the condition being treated and individual patient factors. In clinical trials, the following dosages have been studied:

  • For depression and cognitive symptoms: 200mg daily[1].
  • For cancer-related fatigue: 200mg daily[5].
  • For substance abuse disorders: 200-400mg daily[9].

It’s important to note that modafinil should only be taken under the supervision of a healthcare provider, who will determine the appropriate dosage for each individual patient.

Potential Side Effects

While modafinil is generally well-tolerated, it can cause side effects in some people. Common side effects may include:

  • Headache
  • Nausea
  • Anxiety
  • Insomnia (difficulty sleeping)
  • Dizziness

These side effects are usually mild and may decrease over time. However, if they persist or worsen, it’s important to consult with a healthcare provider[5].

Ongoing Research

Researchers continue to study modafinil for various conditions. Some areas of ongoing research include:

  • Its potential to improve cognitive function in university students[7].
  • Its effectiveness in treating fatigue and cognitive issues in cancer patients[5].
  • Its use in treating cognitive symptoms in patients with depression[1].
  • Its potential as a treatment for substance abuse disorders[9].

While these studies show promise, it’s important to remember that more research is needed to fully understand the benefits and risks of modafinil for these conditions. Patients should always consult with their healthcare provider before considering modafinil for any off-label use.

Condition Studied Key Findings Dosage Used Study Duration
Cognitive impairment in depression Potential improvements in memory, attention, and cognitive flexibility 200 mg daily 8 weeks
Cancer-related fatigue May reduce fatigue and improve cognitive function 200 mg daily 4 weeks
PTSD in combat veterans Possible reduction in PTSD symptoms and improvement in attention 100 mg daily 4 weeks
Cocaine addiction Potential to reduce cocaine use and improve cognitive function 200-400 mg daily 8 weeks
Multiple sclerosis-related fatigue May improve fatigue and cognitive measures Not specified Not specified
Methamphetamine addiction Possible reduction in methamphetamine use and withdrawal symptoms 200-400 mg daily Not specified
Narcolepsy in children/adolescents Evaluation of safety and effectiveness for excessive sleepiness 100-400 mg daily 6 months

FAQ

  • What conditions is modafinil being studied for in clinical trials? Modafinil is being studied for a variety of conditions including cognitive impairment in depression, fatigue in cancer patients, narcolepsy, obstructive sleep apnea, methamphetamine addiction, post-traumatic stress disorder (PTSD), and cognitive enhancement in healthy individuals.
  • What are some potential benefits of modafinil observed in trials? Some potential benefits observed include improvements in cognitive function (e.g. memory, attention, executive function), reduced fatigue, increased wakefulness, and improved work productivity in certain patient groups. However, results vary across studies and more research is needed.
  • What is the typical dosage of modafinil used in clinical trials? Dosages typically range from 100-400 mg per day in most trials. Many studies start patients at 100 mg and increase up to 200-400 mg daily if tolerated. The exact dose depends on the condition being studied and individual patient factors.
  • Are there any common side effects of modafinil reported in trials? Common side effects reported include headache, nausea, anxiety, and insomnia. However, modafinil is generally well-tolerated by most participants. Side effects are usually mild to moderate in severity.
  • Is modafinil approved by the FDA for any of these conditions? Modafinil is FDA-approved for treating excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work sleep disorder. Its use for other conditions like depression or fatigue is considered off-label and still investigational.

Ongoing Clinical Trials on Modafinil

  • Study on Modafinil for Improving Cognitive Deficits in Multiple Sclerosis Patients

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Portugal

  • Modafinil for Severe Fatigue in Patients with Quiescent Inflammatory Bowel Disease

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

Glossary

  • Modafinil: A wakefulness-promoting medication used to treat excessive sleepiness. It is chemically different from stimulants and has a lower risk of abuse. Brand names include Provigil and Alertec.
  • Cognitive function: Mental abilities including memory, attention, problem-solving, and decision-making. Modafinil is being studied for its potential to enhance various aspects of cognition.
  • Fatigue: A feeling of tiredness, lack of energy, or exhaustion. Cancer-related fatigue is a common symptom that modafinil is being investigated to potentially alleviate.
  • Narcolepsy: A chronic sleep disorder characterized by overwhelming daytime drowsiness and sudden attacks of sleep. Modafinil is FDA-approved to treat excessive sleepiness in narcolepsy.
  • Obstructive Sleep Apnea (OSA): A sleep disorder where breathing repeatedly stops and starts during sleep due to blocked upper airways. Modafinil may help with residual daytime sleepiness in treated OSA.
  • Major Depressive Disorder (MDD): A mental health condition characterized by persistent feelings of sadness and loss of interest. Some studies are exploring modafinil's potential to improve cognitive symptoms in MDD.
  • Post-Traumatic Stress Disorder (PTSD): A mental health condition triggered by experiencing or witnessing a terrifying event. Modafinil is being studied as a potential treatment for PTSD symptoms.
  • Neurocognitive Index (NCI): A composite score derived from various cognitive tests, used to assess overall cognitive function in some clinical trials of modafinil.
  • Placebo: An inactive substance used as a control in clinical trials to test the effectiveness of a medication. Modafinil is often compared to placebo in studies.
  • Off-label use: The practice of prescribing a drug for a condition or patient group that it has not been officially approved for by regulatory agencies.

References

  1. https://clinicaltrials.gov/study/NCT03620253
  2. https://clinicaltrials.gov/study/NCT02385656
  3. https://clinicaltrials.gov/study/NCT00208715
  4. https://clinicaltrials.gov/study/NCT00917748
  5. https://clinicaltrials.gov/study/NCT05333250
  6. https://clinicaltrials.gov/study/NCT00220506
  7. https://clinicaltrials.gov/study/NCT01365897
  8. https://clinicaltrials.gov/study/NCT00218387
  9. https://clinicaltrials.gov/study/NCT00538655
  10. https://clinicaltrials.gov/study/NCT01726088